propagermanium has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mimori, K; Nakayama, KI; Sugiyama, S; Yumimoto, K | 1 |
1 review(s) available for propagermanium and Neoplasms
| Article | Year |
|---|---|
Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents.
Topics: Animals; Antineoplastic Agents; Chemokine CCL2; Clinical Trials as Topic; Germanium; Humans; Japan; Mice; Neoplasms; Organometallic Compounds; Propionates; Receptors, CCR2; Signal Transduction; Small Molecule Libraries | 2019 |